BIOTEST BIOTECH
68876738.176.68% ( +2.39 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: BIOTEST BIOTECH(688767) the Revenue is 89.38 M (+1.7%);the EBIT is -4.459 M (-697%);the EPS is -0.07 (-216.7%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.09B1.70%
----
----
EBIT
-0.00B697.01%
----
----
EPS
-0.07216.67%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf